07 Feb News from Norway
The Norwegian Medicines Agency has recently announced a need for more suppliers or alternatives on the market in Norway for the active substances ivermectin and erythromycin, and want to get in contact with possible suppliers. The Norwegian Medicines Agency’s announcement list are applicable for medicinal products deemed as critical to the market, with regard to public health. Possible reasons for shortage...